Notice Number: NOT-CA-06-014
Release Date: March 6, 2006
National Cancer Institute (NCI) (http://www.nci.nih.gov)
This Notice is to inform the scientific community that the NCI is amending Program Announcements PA-06-045, Novel Technologies for In Vivo Imaging (STTR [R41/R42]) and PA-06-046, Novel Technologies for In Vivo Imaging (STTR [R41/R42]), such that Type 2 (Renewal) Phase II competing continuation grant applications will no longer be accepted by the NCI in conjunction with these two funding opportunity announcements from this date through to their expirations on November 2, 2006.
Direct questions about this change to:
Guoying Liu, Ph.D.; Keyvan Farahani, Ph.D.; James A. Deye, Ph.D.; or Houston Baker, Ph.D.
National Cancer Institute
6130 Executive Plaza, EPN Suite 6000, MSC 7412
Bethesda, MD 20892-7412 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Telephone: 301-496-9531 for GL, KF, or HB; 301-496-6111 for JAD
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.